HIV Tat protein requirements for transactivation and repression of transcription are separable

被引:20
作者
Brown, JA [1 ]
Howcroft, TK [1 ]
Singer, DS [1 ]
机构
[1] NCI, Mol Regulat Sect, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1998年 / 17卷 / 01期
关键词
HIV; Tat protein; repression; transactivation; transcription;
D O I
10.1097/00042560-199801010-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV Tat protein, primarily characterized as a transcriptional activator of the viral long terminal repeat (LTR), is also a potent repressor of major histocompatibility complex (MHC) class I transcription. In the present study, we demonstrate that these two functional activities are distinct and mediated by discrete, but overlapping, structural domains of Tat. Tat repressor activity depends on C-terminal sequences, whereas transactivation depends on N-terminal sequences; both functions require core sequences. The repressor activity requires a domain encompassing the region encoded by the second exon of the Tat gene, beginning at amino acid 73, with a C-terminal limit between amino acids 80 and 83. Tat repressor function also depends on the presence of a lysine at position 41, located within the core of the protein. Tat repressor activity is independent of two N-terminal domains essential for transactivation: the acidic segment and the cysteine-rich region. Conversely, Tat transactivation is independent of the second exon-encoded region of Tat. As further support for this novel model of separable Tat functions, we show that in murine fibroblasts, Tat represses class I promoter activity, but does not transactivate the HIV LTR. We propose that distinct structural domains mediate the two functionally distinct activities associated with the Tat protein.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 39 条
[1]   THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, A GROWTH-FACTOR FOR AIDS KAPOSI-SARCOMA AND CYTOKINE-ACTIVATED VASCULAR CELLS, INDUCES ADHESION OF THE SAME CELL-TYPES BY USING INTEGRIN RECEPTORS RECOGNIZING THE RGD AMINO-ACID-SEQUENCE [J].
BARILLARI, G ;
GENDELMAN, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7941-7945
[2]   FUNCTIONAL ROLES FOR THE TATA PROMOTER AND ENHANCERS IN BASAL AND TAT-INDUCED EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT [J].
BERKHOUT, B ;
JEANG, KT .
JOURNAL OF VIROLOGY, 1992, 66 (01) :139-149
[3]   TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM [J].
CULLEN, BR .
CELL, 1986, 46 (07) :973-982
[4]   IDENTIFICATION OF NEGATIVE AND POSITIVE REGULATORY ELEMENTS ASSOCIATED WITH A CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE [J].
EHRLICH, R ;
MAGUIRE, JE ;
SINGER, DS .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :695-703
[5]   TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPRESSES EXPRESSION OF MANGANESE SUPEROXIDE-DISMUTASE IN HELA-CELLS [J].
FLORES, SC ;
MARECKI, JC ;
HARPER, KP ;
BOSE, SK ;
NELSON, SK ;
MCCORD, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7632-7636
[6]   HUMAN CHROMOSOME-12 IS REQUIRED FOR ELEVATED HIV-1 EXPRESSION IN HUMAN-HAMSTER HYBRID-CELLS [J].
HART, CE ;
OU, CY ;
GALPHIN, JC ;
MOORE, J ;
BACHELER, LT ;
WASMUTH, JJ ;
PETTEWAY, SR ;
SCHOCHETMAN, G .
SCIENCE, 1989, 246 (4929) :488-491
[7]   Measure of transient transfection efficiency using beta-galactosidase protein [J].
Howcroft, TK ;
Kirshner, SL ;
Singer, DS .
ANALYTICAL BIOCHEMISTRY, 1997, 244 (01) :22-27
[8]  
HOWCROFT TK, 1995, IMMUNITY, V3, P127
[9]   REPRESSION OF MHC CLASS-I GENE PROMOTER ACTIVITY BY 2-EXON TAT OF HIV [J].
HOWCROFT, TK ;
STREBEL, K ;
MARTIN, MA ;
SINGER, DS .
SCIENCE, 1993, 260 (5112) :1320-1322
[10]   IN-VITRO AND IN-VIVO BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN AND SP1 TRANSCRIPTION FACTOR [J].
JEANG, KT ;
CHUN, R ;
LIN, NH ;
GATIGNOL, A ;
GLABE, CG ;
FAN, H .
JOURNAL OF VIROLOGY, 1993, 67 (10) :6224-6233